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refusal of VTE prophylaxis doses is the most common documented reason these
doses are not administered. A small number of patients and nursing units account
for a vast majority of refused doses. We have initiated a mixed-methods investi-
gation to determine what patient, nursing unit, and culture of care-level factors
may explain refusal of these doses.
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OBJECTIVES: To assess the impact of pharmacist-led face-to-face counseling on
prescription first refill rate in patients who are new to statins or thyroid
medications. METHODS: A retrospective pre-post with case-control cohort study
design was employed. In May 2010, two community pharmacies implemented
face-to-face counseling by trained pharmacists at the site of care when patients
initially filled their statin or thyroid prescriptions. Patients’ first refill rate, defined
as percentage of patients who refilled their prescriptions within a two-week’s pe-
riod after exhaustion of their initial fill, was assessed as the primary outcome
measure. Similar computations were performed for patients’ who filled their study
medications at the two stores, 12-months prior to the intervention program. Addi-
tionally, two control pharmacy stores were selected based on pharmacy type, op-
erational years of stores, prescription volume, and corresponding population char-
acteristics. Refill rates in the pre and post-periods were also computed for control
stores. A chi-square test was performed to investigate the relationship between
face-to-face intervention and patients’ first refill rate. RESULTS: Test stores that
implemented face-to-face counseling, conducted interventions on 81 new to ther-
apy patients in the post period, while a total of 76 (new to therapy patients) were
included in the pre-period. A total of 73 and 81 new to therapy patients were
selected from control stores in the pre and post-period respectively. For test stores,
chi-square analyses showed a significant increase in the refill rates in the post-
period as compared to the pre-period (Pre-period: 55.7% Vs Post-period: 70.4%
p0.01), whereas control stores did not show any significant increase across two
periods (Pre-period: 56.2% Vs Post-period: 61.7%, p0.05). CONCLUSIONS: Pharma-
cist-led face-to-face counseling had a positive impact on patient’s refill behavior.
The study showed an early impact of the program; additional larger pilot studies
and longer follow-up period are needed to better understand the full benefit of the
program.
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OBJECTIVES: To measure and compare the extent of medication compliance in
elderly and geriatric hypertensive cohorts. To evaluate the role of illness percep-
tions and investigate how medication beliefs and dimensions of illness percep-
tions, might impact medication compliance outcome in hypertension.METHODS:
A cross-sectional research design, utilizing convenience sampling strategies and
self-administered surveys of elderly hypertensive residents living inNewYork City
senior care centers (N117).Medication compliancewasmeasured usingMorisky’s
test; medication beliefs were measured using Beliefs about Medication Question-
naire (BMQ), and illness perceptions using Brief Illness Perceptions Questionnaire
(BIPQ). RESULTS:MajoriMajority of the population was white (75%). There were no
significant differences observed demographically between the elderly (55-65 years)
and geriatric (65 years) samples except with respect to college education (53% vs.
47%). About 46% of the elderly sample was noncompliant with hypertension med-
ications, compared to 63%whowere 65 years and older (geriatric). BIPQ component
scores correlated positively with medication compliance score across both elderly
and geriatric samples (r 0.134; p0.496 and r 0.447; p0.000, respectively). The
score on Specific Necessity Beliefs dimension associated positively with Morisky’s
Test score across both the cohorts (r0.027, p0.892 and r0.297; p0.020),
whereas General Harm and General Overuse Beliefs about medication correlated
negatively with medication compliance. A majority of the participants rank-or-
dered stress as the number one cause of their illness (49.1%), followed by ‘lifestyle’
(43.8%) and ‘hereditary factors’ (7.1%). CONCLUSIONS:Medication noncompliance
seems to worsen with an increase in age. Stronger necessity beliefs and more
favorable perceptions about the illness are observed in geriatrics compared to el-
derly. The study underscores the importance of incorporating patient perceptions
about illness and medication beliefs into disease management frameworks that
seek to build medication compliance in hypertension.
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OBJECTIVES: To examine patterns of medication adherence and persistence with
antihypertensive or statin therapies among uninsured working-adults enrolled in
the Texas DMIE Study. METHODS: This study was a randomized controlled trial
(RCT) conducted to assess the effects of an intervention (i.e., improved medical
services and subsidized drug-copay) among uninsured working-adult participants
age 21-65 years, receiving medical services in the Harris County Health District.
Cardiovascular medication adherence and persistence were measured separately
for participants prescribed either statin or antihypertensive (i.e.,angiotensin-con-
verting-enzyme-inhibitor or angiotensin-receptor-blocker) therapy during an 18-
month period. Medication adherence was calculated as the proportion of days
covered (PDC). Participants were “adherent” when PDC 80%. Persistence was
measured as a 35-day gap between drug refills. Logistic regression and cox pro-
portional hazards models evaluated potential predictors of adherence and
persistence. RESULTS: For participants on statin therapy (N449), a higher mean
PDC (p0.01) was observed in the intervention cohort (0.61[SD0.27]) versus
control (0.51[SD.30]). Switching statins and titration adjustments were signif-
icant predictors of adherence. Adjusting for covariates, the intervention
(OR1.28[CI95%,1.01,2.68]) wasmore likely to be adherent to statins versus control.
Mean persistence with statins in the intervention was 230-days compared to 171-
days for control group participants. The intervention was less likely to experience
a refill gap (OR0.69[CI 95%,0.51,0.92]) versus control. For antihypertensive drugs
(N636), mean PDC in the intervention was 0.65 (SD0.27) versus 0.60 ((SD0.28)
for control (p0.02). Predictors of adherence included race/ethnicity, polyphar-
macy, and depression. The intervention group (OR1.32[CI 95%,1.07,2.88]) was
more likely to be adherent versus control. Mean persistence with antihyperten-
sives in the intervention was 291-days versus 257-days for control. No significant
difference in persistence seen between intervention and control. CONCLUSIONS:
This RCT showed improved adherence to statin and antihypertensive medications
among the intervention cohort. Findings from this studywould be useful in guiding
ongoing efforts to optimize cardiovascular-drug adherence targeted toward unin-
sured working-adults.
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OBJECTIVES: This study examined stroke risk and prevention among US patients
diagnosed with atrial fibrillation (AF).METHODS: Data were extracted from the US
2010 National Health and Wellness Survey, an annual, Internet-based, cross-sec-
tional database of 75,000 adults (age18). Stroke risk was assessedwith CHADS2,
determined by presence of congestive heart failure, hypertension, diabetes melli-
tus, old age (75 years), and history of stroke or transient ischemic attack. Low-
(CHADS2  0), moderate- (1), and high- (2) risk patients reported which steps, if
any, they took to prevent stroke: low fat or low sodium diet, regular exercise,
smoking cessation, weight loss, blood pressure or cholesterol reduction, or use of
baby aspirin, aggrenox, warfarin, clopidogrel, or other medications. High-risk pa-
tients were compared with low and moderate-risk patients, adjusting for socio-
demographic and health characteristics using logistic regression models.
RESULTS:Among 1,350 respondents diagnosedwithAF (projectedUSprevalence of
1.49%), 308 (22.8%) were low, 473 (35%) moderate, and 569 (42.2%) high in risk of
stroke. High- vs. low-risk patients were significantly more likely to take any pre-
ventative steps (60.5% vs. 34.1%, respectively; OR2.75, p0.001). Furthermore,
high-risk patients were significantly more likely to take steps to lower their blood
pressure (OR8.33, p0.001), cholesterol (OR2.46, p0.007), use clopidogrel
(OR7.46, p0.027) or other stroke-prophylactic medications (OR3.32, p0.003)
compared with low-risk patients. No differences were observed on lifestyle modi-
fication such as diet, exercise or smoking cessation. CONCLUSIONS: These results
suggest, US adults at high risk of stroke are more likely to take steps to lower high
blood pressure and cholesterol, and to use medications to prevent stroke, com-
paredwith low-risk individuals. No significant differences emerged on diet, regular
exercise, smoking cessation and aspirin use. Higher risk correlated with higher
prevention, yet there remains an unmet need for increased targeted treatment and
lifestyle changes for high-risk AF patients.
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OBJECTIVES: To assess themeasurement properties and validity of Health Utilities
Index Mark 3 (HUI3) Japanese version for stroke patients in Japan.METHODS: The
HUI3 was administered 553 patients with stroke who were admitted in seven hos-
pitals. Proxies of the patients completed Japanese version of the HUI3 question-
naires at start phase of rehabilitation. Patients were categorized using modified
Rankin scale (MRS). The construct validity was assessed by analyzing the degree to
which lower score on the HUI3 scores correlated positively with MRS. RESULTS:
Mean global score was as follows: MRS 10.62 (SD0.22), MRS 20.48 (SD0.28),
MRS 30.27 (SD0.24), MRS 40.00 (SD0.18), MRS 5 0.23 (SD0.11). Worst
mean single score was ambulation (0.29) and, subsequently cognition (0.49), and
dexterity (0.58). CONCLUSIONS: Our results indicate the productive future for Jap-
anese HUI3 use and showed precise measuring properties of the HUI3 Japanese
version in assessing health status for stroke patients.
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